The clinical diagnosis of dopamine biomarkers plays a crucial role in classifying nervous system-related disorders, which are increasingly prevalent across all age groups worldwide. Accurate and thorough diagnosis is essential for administering appropriate drug therapies. However, it has been observed that there is a scarcity of diagnostic methods available in the market, highlighting a significant demand for such tools, particularly as the healthcare system transitions towards personalized medicine. This growing demand has garnered significant attention from researchers working in diagnostics. It is of great therapeutic and pharmacological significance to design and develop diagnostic instruments for the monitoring of dopamine levels both in vivo and in vitro. Extensive research efforts have been dedicated to devising realistic diagnostic techniques for assessing dopamine levels in bodily fluids, with a particular focus on electrochemical sensing methodologies. While studies related to electrochemical sensing of dopamine have shown promising advancements in terms of simplicity, speed, and sensitivity, there remains a notable gap in their application for clinical studies. Thus, this review aims to provide an overview of the latest progress in non-enzymatic (enzyme-free or direct electrochemical) electrochemical sensing of dopamine, specifically focusing on its integration with carbonaceous nanomaterials in electrodes. Additionally, the review discusses the potential for the commercialization of these laboratory-proven techniques soon, emphasizing their feasibility and practicality in real-world applications.